Writer and podcaster covering health, science, politics and medical cannabis.
Could cannabidiol (CBD), the most prominent non-psychoactive constituent in cannabis, provide a viable alternative for currently available anxiety medications? Quite possibly!
Since 1980, surgical procedures and treatments have improved significantly, cutting the risk of developing blindness nearly in half. Nonetheless, while treatment has improved, the number of effective topical drugs remains limited. Recognized near universally in medical marijuana states as a qualifying condition, increasing numbers of people have turned to cannabis to treat their condition. But should they?
For most consumers, “high-octane” THC is ill-suited for them on many levels. High THC is therapeutically less effective. It’s not as enjoyable. And, it’s far more likely to produce adverse — short and long-term — effects.
Cannabis can make people feel more relaxed, less stressed, and, of course, happier. So predictably, people experiencing depression or anxiety are much more likely to use cannabis — and more of it — than people not suffering from these conditions.
Each year in just the U.S., nearly 52,000 people die from TBI and 80,000 sustain severe disabilities. Compare that to car fatalities (32,675) and homicides (14,196), which combined claim fewer lives. Moreover, 5.3 million people in the U.S. live with TBI-related disabilities, a number comparable to those living with Alzheimer's disease.
The Multiple Sclerosis Foundation estimates that every week in the U.S., 200 people will learn they have multiple sclerosis (or as it’s more commonly called, MS). People like Jabe Couch, a father and husband from the Pacific Northwest. Few conditions are as long-lasting and progressively debilitating as MS, which causes damage to the brain, spinal cord, and affects the body’s immune system. A diagnosis can be devastating.
According to the VA National Center for PTSD, 8 million people — or 7 – 8% of the population — will experience PTSD at some point in their lives. Given the epidemic of addiction and overdose deaths from prescription drugs including opioids and benzodiazepines, the field of emotional trauma is currently at a crossroads.
The medical marijuana community was disappointed to learn the nation’s top drug law enforcement agency — the Drug Enforcement Agency (DEA) — decided against rescheduling cannabis from Schedule I to a lower schedule, like Schedule II.
Commonly prescribed drugs like opioids are highly addictive and potentially toxic; 28,000 people died from an opioid overdose in 2014, more than any other year in history. No wonder a growing number of the estimated one in five Americans who suffer from chronic pain are turning to cannabis as an alternative.
After nearly a century of “reefer-madness”-inspired paternalistic federal obstructionism, the Drug Enforcement Agency’s announcement that it won’t reschedule cannabis should come as no surprise.
Given the increasing prevalence of hypertension at a time when states are liberalizing cannabis laws, people want to know: what are the effects of cannabis on blood pressure? Does it lower blood pressure? The answers largely depend on who you ask or what study you read.
Can Cannabis Treat Fibromyalgia Better Than Prescription Drugs? Anyone suffering from fibromyalgia will tell you it can be devastating. On some days, simple chores like doing laundry or making breakfast can be exhausting, if not downright impossible.
As cannabis sheds the stigma that has long been associated with its use, more people are speaking out about how cannabis has helped them deal with mental illness. - Leafly
Cannabis and the brain is a meaty subject. Identifying the various ways cannabis affects the brain is complicated, and we've only just begun to unravel many of the mysteries.
You've probably heard of the commonly held myth about the chemical that is blamed (or credited) for the cannabis “high”: dopamine. Many media reports over the past few decades explain that THC induces a “flood of dopamine” that causes the pleasurable “high” cherished by recreational cannabis consumers.